Search Within

Michal F Segal

  1. "Advanced Practice Providers"
Formats
  1. Meeting Abstract (4)
  2. Journal Article (2)
Groups
  1. Advanced Practice Providers (6)
  2. Department of Medicine (6)
  3. Gastrointestinal Oncology Service (6)
  4. Nursing (6)
  5. Solid Tumor Oncology Division (6)
  6. Center for Pancreatic Cancer Research (5)

More Groups

People
  1. Ellen Hollywood (6)
  2. Leonard Saltz (4)
  3. Laura Tang (3)
  4. Marinela Capanu (3)
  5. Andrew Epstein (2)
  6. David Kelsen (2)

More People

Years
  1. 2014 (1)
  2. 2013 (1)
  3. 2012 (1)
  4. 2011 (2)
  5. 2010 (1)
Publications
  1. Journal of Clinical Oncology (3)
  2. Cancer (1)
  3. Oncology (1)
  4. Pancreas (1)
Publishers
  1. American Society of Clinical Oncology (3)
  2. Lippincott Williams & Wilkins (1)
  3. S. Karger AG (1)
  4. Wiley Blackwell (1)

Results (6)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase IB trial of cisplatin (C), gemcitabine (G), and veliparib (V) in patients with known or potential BRCA or PALB2-mutated pancreas adenocarcinoma (PC)
    Meeting Abstract

    O'Reilly, E. M.; Lowery, M. A.; Segal, M. F.; Smith, S. C.; Moore, M. J.; Kindler, H. L.; Golan, T.; Segal, A.; Salo-Mullen, E. E.; Hollywood, E.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Randomized phase II study of gemcitabine (G), cisplatin (C) with or without veliparib (V) (arms A, B) and a phase II single-arm study of single-agent veliparib (arm C) in patients with BRCA or PALB2-mutated pancreas adenocarcinoma (PC)
    Meeting Abstract

    O'Reilly, E. M.; Lowery, M. A.; Yu, K. H.; Capanu, M.; Stadler, Z. K.; Epstein, A. S.; Golan, T.; Segal, A.; Segal, M.; Salo-Mullen, E. E.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • A phase 2 study of the insulin-like growth factor-1 receptor inhibitor MK-0646 in patients with metastatic, well-differentiated neuroendocrine tumors
    Journal Article

    Reidy-Lagunes, D. L. ; Vakiani, E.; Segal, M. F.; Hollywood, E. M.; Tang, L. H.; Solit, D. B.; Pietanza, M. C.; Capanu, M.; Saltz, L. B.
    Cancer (2012)

    Fulltext@MSK | Save
  • Phase I study of two schedules of oral S-1 in combination with fixed doses of oxaliplatin and bevacizumab in patients with advanced solid tumors
    Journal Article

    Chung, K. Y.; Saito, K.; Zergebel, C.; Hollywood, E.; Segal, M.; Saltz, L. B.
    Oncology (2011)

    Fulltext@MSK | Save
  • A phase II clinical T trial of MK-0646, an insulin-like growth factor-1 receptor inhibitor (IGF-1R) in patients with metastatic well differentiated neuroendocrine tumors (NETs)
    Meeting Abstract

    Reidy, D. L.; Hollywood, E.; Segal, M.; Saltz, L.
    Pancreas (2011)

    Fulltext@MSK | Save
  • A phase II clinical trial of MK-0646, an insulin-like growth factor-1 receptor inhibitor (IGF-1R), in patients with metastatic well-differentiated neuroendocrine tumors (NETs)
    Meeting Abstract

    Reidy, D. L.; Hollywood, E.; Segal, M.; Saltz, L.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save